C
Market Data
$31.30−$4.93 (−13.61%)
COGT · Last trade
Prev Close
$36.23
Range (31d)
$31.30 – $37.09
Recent Filings
- 8-K138.6 KBCogent Biosciences, Inc.Sep 2, 4:11 PM ET·0001193125-26-380194
- 1445.0 KBCogent Biosciences, Inc.Aug 27, 4:17 PM ET·0001950047-26-008754
- SCHEDULE 13G/A17.3 KBCogent Biosciences, Inc.Aug 13, 4:10 PM ET·0001193805-26-001082
- 8-K155.4 KBCogent Biosciences, Inc.Aug 10, 5:19 PM ET·0001193125-26-342695
- 10-Q8.5 MBCogent Biosciences, Inc.Aug 10, 4:11 PM ET·0001193125-26-342393
- 8-K375.7 KBCogent Biosciences, Inc.Aug 10, 8:06 AM ET·0001193125-26-341315
- SCHEDULE 13G7.6 KBCogent Biosciences, Inc.Jul 31, 9:55 AM ET·0002100119-26-001323
- SCHEDULE 13G/A11.3 KBCogent Biosciences, Inc.Jul 27, 4:25 PM ET·0002012383-26-002235
- 8-K149.5 KBCogent Biosciences, Inc.Jun 11, 4:15 PM ET·0001193125-26-267566
- 10-Q7.4 MBCogent Biosciences, Inc.May 5, 8:21 AM ET·0001193125-26-205170
Insiders
10- Aldag JornDirector
- Atlas Venture Associates IX, LLC10% Owner
- Atlas Venture Associates IX, L.P.10% Owner
- Atlas Venture Fund IX, L.P.10% Owner
- Booth BruceDirector
- CAIN CHRISTOPHER W.Director
- CAMPANA DARIO10% Owner
- Ettenberg SethChief Scientific Officer
- Fairmount Funds Management LLCDirector
- Ferrante Karen JeanDirector
Tickers
Addresses
business
180 THIRD AVENUE 4TH FLOOR
WALTHAM, MA
mailing
180 THIRD AVENUE 4TH FLOOR
WALTHAM, MA
Former Names
- Unum Therapeutics Inc.2020-10-05
- Unum Therapeutics, Inc.2018-03-30